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tics in VT pts were larger diminution of TWA after beta-bieckade and smaller increase 
during beta-stimulation; suggesting an augmentation of intrinsic beta-adrenergic activity 
in VT pts. 
Effect of PRO and ISP on eMV In lots with and without VT. 
* P < 0.05 versus baseline 
VT Non VT VT Non VT 
90 ppm 90ppm 110ppm 110ppm 
baseline 1.32+/-0.47 0.29+/-0.29 2.45+/-0.97 1.16+/-0.94 
PRO 0.47+/-0.33* 0.28+/-0.48 0.89+/-0.40* 0.45+/-0.65* 
ISP 1.58+/-1.73 1.67+/-1.84 3.06+/-2.01 3.88+/*3.82 
1093-108 Female Gender Is Associated With a Decreased 
Prevalence of T Wave Alternans 
Laura A. Murehv, Eric J. Rashba, Stephen R. Shorofsky, Karen MacMurdy, Michael R. 
Gold, University of Maryland, Baltimore, Maryland. 
Background: Gender has important influences on cardiovascular disease including 
arrhythmias. Women have a lower incidence of sudden cardiac death (SCD), but the 
mechanisms underlying this observation are poorly understood. T-wave altemans (TWA) 
is an important marker of ventricular arrhythmia vulnerability. However, the effects of gen- 
der on this measure have not been evaluated. 
Methods: This was a prospective study of 251 patients with ischemic heart disease and 
left ventricular dysfunction (ejection fractions < 40%). The patients underwent electro- 
physiology study (EPS) and measurement of TWA as part of the evaluation of suspected 
ventricular arrhythmias in the absence of antiarrhythmic drugs or beta blockers. 
Results: The cohort was 19% female with a mean age of 65 + 10 years and a mean 
ejection fraction of 27 + 8%. Women had higher ejection fractions (29 + 9 vs. 27 :.+ 8, 
p=0.03), lower rates of inducible arrhythmias (56% vs 69%, p= 0.09), were less likely to 
be receiving beta blockers chronically (48% vs 67%, p= 0.02) and were less likely to 
have positive "I3NA tests (42% vs 63%, p=O.02). Multivariate analysis of 10 clinical factors 
using "I3NA as the dependent variable revealed that female gender (OR 0.4, 95% CI 0.2- 
0.8, p=0.007), age (OR 1.04 per year interval, 95% CI 1.01-1.07, p=0.O07), and digoxin 
therapy (OR 2.5, 95% CI 1.3-4.7, p=0.006) were independent predictors of "I'WA. 
Conclusions: Women are less likely to have abnormal TWA. Since TWA may be mech- 
anistically related to the pathogenesis of SCD, this finding could contribute to the lower 
incidence of SCD among women. 
1093-109 Different Characteristics of T Wave Alternans Between 
Polymorphic Ventricular Tachycardia and Monomorphic 
Ventricular Tachycardia 
Kaoru Tanno. Youichi Kobayashi, Takashi Katagiri, Showa University, Tokyo, Japan. 
[Background] Micrevolt T wave alternans (TWA) has been reported to be closely associ- 
ated with polymorphic ventricuier tachycardia (VT) in animal experiments. However, it is 
not clear whether monomorphic VT (monoVT) has relation to TWA as closely as poly- 
morphic VT (polyVT). [Method] The subjects were 59 patients (male/female=51/8, mean 
age 60 ± 13 years) with organic heart disease and ventdcuier tachyarrhythmias. We 
compared "I3NA of patients with polyV'l" with that of patients with monoV'l'. Programmed 
ventricular stimulation was performed at nght ventricular apex and outflow tract to induce 
sustained ventdcular techyarrhythmias. Recordings of TWA were made in sinus rhythm 
and with atrial pacing at 80, 90, 100, and 110 beat per minute if conducted without atdo- 
ventricular block for 3 minutes respectively with CH2000 system (Cambridge Heart Co. 
Boston, MA). TWA was considered positive when the alternans voltage (Valt) was 
>1.9~V and the alternans ratio was >3 for a period of more than 1 minute in VM, X, Y, Z, 
or two adjacent precordial leads. 
[Results] Electrical stimulation induced polyVT in 13 patients and monoVT in 20 patients. 
TWA was positive in all patients in polyVT group, while 15 of 20 patients in monoV'l" 
group had positive TWA. Although onset heart rate was not significantly different 
between two groups, onset heart rate/target heart rate (220-age) of polyVT group was 
significantly lower than the other group (polyVT: 58 ± 11 vs. monoVT: 63 ± 8, None: 68 ± 
9 %, p<O.05). Valt of polyVT group at X lead during 110 bpm was significantly higher than 
the other group (polyVT: 3.6 ± 2.4 vs. monoVT: 1.4 ± 1.3, None: 1.8 ± 1.9p.V, p<0.05). 
During 29 ± 12 months follow-up periods, Vf recurred in 4 patients of polyVT group and 
VT recurred in 7 patients of monoVT group. All patients with recurrence of ventricuier 
tachyarrhythmias were positive in TWA. 
[Conclusion] Polymorphic VT could be more closely associated with TWA than mono- 
morphic VT. Microvolt TWA might be a powerful tool for predicting recurrence of ventricu- 
lar tachyarrhythmias in patients with organic heart disease. 
1093-11 0 Ef fect  of  B -B locker  Therapy for T-Wave Alternans and 
Cardiac Sympathetic Function in Patients With 
Nonischemic Heart Disease 
Mariko Murata. Masahiko Harada, Akihiko Shimizu, Makoto Kubo, Reo Mitani, Yuka 
Dairaku, Masunori Matsuzaki, The Second Department of/ntema/Medicine, Yamaguchi 
University School of Medicine, Ube, Japan, The Faculty of Health Science, Yamaguchi 
University School of Medicine, Ube, Japan. 
Background: We have reported that cardiac sympathetic denervation was related to the 
presence of T-wave alternans (TWA) in patients with non-ischemic heart disease (NIHD) 
in the previous ACC meeting. Recently, it has been observed that mechanical alternans 
disappeared with the improvement of left ventricular ejection fraction (EF) with R-blocker 
therapy in patients with DCM. The aim of this study was to investigate whether 1-VVA find- 
ings also improve together with the improvement of cardiac sympathetic denervation and 
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EF with B-blocker in positive TWA patients with NIHD. 
Methods: Eighteen positive TWA patients with NIHD not treated with 13-blockers were 
enrolled. The TWA test, 1-123 metaiodobenzylguanidine (MIBG) scintigraphy, and 
echocardiography were performed at baseline and after 3 months of treatment with 13- 
blockers. Using alternans voltage of the vector magnitude (Valt) in the TWA test, the 
decrease rate of Valt (% Valt) was calculated {% Valt=(pre Valt- post Valt)/pre Valt "100; 
pre: before administration, post: after administration}. The heaWmediastinal count ratios 
in the eady phase (ell/M) and delayed phase (dH/M), and the washout rate (WR) were 
calculated using MIBG scintigraphy, and EF was measured with echocardiography. The 
rate of change between baseline and after administration was calculated using the fol- 
lowing formula {% eH/M=(post ell/M- pre eH/M)lpre eH/M "100, % dH/M=(post dH/M- 
pre dH/M)/pre dH/M "100, % WR=(post WR- pre WR)/pre WR "100, % EF=(post EF- pre 
EF)/pre EF "100}. Simple regression analysis was performed to examine the relationship 
between each parameter obtained from MIBG or echocardiography and % Valt. 
Results: Significant negative correlations were recognized between pre ell/M, pre dH/M 
or pre EF and % Valt (ell/M: R =0.62, p < 0.01, dH/M: R =0.62, p <0.01, EF: R=0.52, 
p<0.05). Significant positive correlations were also seen between % el-I/M, % dH/M or % 
EF and % Valt (% ell/M: R =0.57, p < 0.05, % dH/M: R =0.68, p < 0.01, % EF: R =0.50, p 
< 0.05). 
Conclusion: TWA findings improved together with the improvement of cardiac sympa- 
thetic denervation and EF with 0-blocker therapy in positive TWA patients with denerva. 
tion and systolic dysfunction. 
1093-111 Combination of Dispersions of QRS Duration and QT 
Interval Improves a Predictive Value of Mortality In 
Patients With Mild to Moderate Chronic Heart Failure 
Takahise Yamada, Masatake Fukunami, Tsuyoshi Shimonagata, Kazuaki Kumagai, Akio 
Hirata, Mitsutoshi Asei, Hidetaka Kioka, Nodtake Hoki, Osaka Prefectural General 
Hospital, Osaka, Japan. 
Background: The possible predictive value of the dispersion of QRS duration (QRSd) as 
the marker of the inhomogenity of ventricular depolarization is unknown in patients with 
chronic heart failure (CHF), although QT dispersion (QTd) as the marker of the inho- 
mogenity of ventricular repolarization has been reported to be related to poor prognosis 
in patients CHF. The aim of this study is to prospectively evaluate the prognostic signifi- 
cance of QRSd and to compare the predictive value of QRSd with that of QTd in patients 
with mild to moderate CHF. 
Methods: We studied 87 consecutive stable outpatients with sinus rhythm whose radio- 
nuclide left ventricular ejection fraction was less than 40% (30-J:8%, NYHA: 1.9-~0.7). 
Before the entry, the signal-averaged ECG was recorded from the standard 12 leads, 
and QRSd was defined as the difference between the maximum and minimum of filtered 
QRS duration in all of the leads. QTcd was determined by subtracting the shortest cor- 
rected QT interval by the Bazeft's formula from the longest one in the standard 12-lead 
ECG. We calculated QTcd at rest and just after Master double stress test (QTcd[ex]). 
Results: During the follow-up period of 49-J:18 months, 11 patients had cardiac death 
(sudden death in 9 and heart failure death in 2). At multivariate Cox analysis, out of the 
variables including clinical, hemodynamic, echocardiographic, neurohumoral parame- 
ters, QRSd and QTcd[ex] was independently associated with the cardiac death 
(QRSd:p=0.0002, hazard ratio 1.268 [1.121 to 1.433]; QTcd[ex]: p=0.01, hazard ratio 
1.034 [1.008 to 1.061]). Kapien-Meier analysis revealed that the cardiac death were sig- 
nificantly (p=0.0015) more often observed in patients with both abnormal QRSd (>25ms) 
and QTcd[ex] (>62ms) than those with either abnormal QRSd or QTcd[ex]. The positive 
predictive value was significantly greater in patients with both abnormal QRSd and 
QTcd[ex] than those with either abnormal QRSd or QTcd[ex] (63% vs 15%, p=O.01). 
Conclusion: The combination of dispersions of QRS duration and QT interval would 
identify higher risk subset of cardiac death in patients with mild to moderate CHF. 
ORAL  CONTRIBUTIONS 
815 Insights Into Biventricular Pacing for 
Congestive Heart Failure 
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11:00 a.m. 
815-1 Reverse Mechanical Remodeling by Biventrlcular 
Pacing in Congestive Heart Failure: One-Year Results 
From Patients in Sinus Rhythm in the MUSTIC (MUItisite 
STimulation In Cardiomyopathy) Study 
Cecilia Linde. Serge Cazeau, Lukas Kappenberger, Richard Sutton, Christophe Bailleul, 
Jean-Claude Daubed, on behalf of the MUSTIC Study Group, Karolinska Hospital, 
Stockholm, Sweden. 
Background: The MUSTIC study is a controlled multicentre trial, to assess the clinical 
efficacy of biventricular pacing (BIV) in patients with chronic NYHA III heart failure and 
intrinsic QRS >150 or RV paced QRS >200 ms. We have reported symptomatic relief 
from the crossover phase (CO) with sustained results over a year. The aim of this study 
was to assess if left ventdcular function improves over time in the group of patients with 
sinus rhythm with no pacing indication. 
Methods: Of 67 included patients 48 completed the 6 month CO single blind comparison 
of BIV and no-BIV. Of these 46 preferred and were programmed to BIV and followed lon- 
gitudinally by clinical parameters, Doppler echocardiography and left ventdcular (LV) 
ejection fraction measured by radionucleides. 
r..~, 
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Results: The LV ejection fraction increased from 24.5 ± 7.8 % at randomisation (rand) to 
30.0 + 12.1% after I year of BIV (p<0.05). LV function by Doppler echo i.e. diastolic fill- 
ing time (DFT), left ventdcular enddiastolic and systolic diameters (LVEDD, LVESD) and 
mitrai regurgitation (MR) are given in the Figure. 
Conclusion: In parallel with a sustained clinical improvement left ventdcular function pro- 
greselvely improved by biventricular pacing in these patients with severe heart failure, 
sinus rhythm and intraventricular conduction delay. 
Rand BIV-CO BIV 9M BIV 12M 
n=67 n=48 n=45 n=43 
LVEDD (mm) 74+10 69±11 *** 68+10"** 67+12*** 
LVESD (mm) 63±10 58± 12*** 56±11 ** * 57±12*** 
MR area (cm =) 7.8±7.8 5.6±8.3 4.9-3:4.6** 4.3¢4.0"* 
DFT (ms) 375±136 430~137" 471+154"* 425±129" 
M=months, *p<O.05, **p<0.01, ***p<0.001, all compared to randomization 
11:15 a.m. 
815-2 Do Heart Fai lure Pat ients  With Right Bundle Branch 
Block Benefit From Cardiac Resynchronization 
Therapy?  Ana lys i s  o f  the  MIRACLE Study  
Juan M. Arenda. Jr.. Anne B. Curtis, Jamie B. Conti, Susan Petereon-Stejskal, University 
of Florida Department of Medicine, Galnesville, Florida. 
Background: Cardiac rasynchronization therapy (CRT) through atriel-tdggered biventricular 
pacing has been proposed as a treatment for heart failure patients with intraventricular con- 
ductlon delays. Previous studies wi~ small heart failure patiant populations have predominan- 
tsb/included patients with left bundle branch block (LBBB) rather than dght bundle branch 
block (RBBB). 
Objective: To determine whether there is a difference in response to CRT between heart fail- 
ure patients with LBBB and heart failure patients with RBBB. 
Methods: The Multi.center InSync Randomized Clinical Evaluation is a large, randomized, 
double-blind study to assess the efficacy of CRT in advanced heart failure patients with a QRS 
duration of >130 msec. In this trial, heart failure patients with CRT had improvement in New 
York Heart Association (NYHA) functional class, quality of life score and distance walked in 6 
minutes compared to patients with no CRT. In this analysis, the changes in these pdmary end- 
points at 6 months from baseline were compared between heart failure patients with LBBB 
and heart failure patients with RBBB. 
RemJff~: Of the 219 patients who completed the 6-menth follow-up, 203 had LBBB, and 16 
had RBBB. Age gender, NYHA functional class, QRS duration, left ventricuiar ejection fraction, 
left ventdoular end diastolic diameter, and heart failure medications were the same at baseline 
for LBBB and RBBB gr~Jps. RBBB patients were more likely to be of Afncan American ethnic- 
ity (LBBB 80, RBBB 25% (p=0.0Ot)) and to have a higher resting heart rats (I_BBB 74 beats 
par minute, RBBB 82 beats par minute (/;=0.02)), There was no difference between groups 
with respect to changes in NYHA functional class (p=0.221), quality of life score (,o=0.315), or 
distance walked in 6 minutes (/:3=0.642). 
Conclusion: Heart failure patients with RBBB obtain the same benefits from CRT as heart 
failure patierds with LBBB. Heart failure patients with RBBB should not be excluded from CRT. 
11:30 a.m. 
815-3 Upgrade to  B lventr lcu lar  Pac ing In Advanced Heart 
Failure Patients Prsvlously Implanted With a 
Conventional Pacemaker for a Class ical  Ind icat ion:  Is It 
Worth  It ? 
Chdstophe Leclercq, Chdstine Alonso, Florence Revault d'AIIonnas, Dominique Pavin, 
Philippe Mabo, Jean C. Daubed. University Hospital, Rennes, France. 
The therapeutic value of biventdcular (BIV) pacing has recently been validated in patients 
with advanced heart failure (AHF), wide QRS complex, and without any classical pace- 
maker (PM) indication. But is this new treatment also suitable for AHF patients previously 
implanted with a conventional PM for a classical indication, and presenting with wide paced 
QRS complex (> 200 ms) ? The aim of this study was to compare the Iong-tarm clinical 
effects of permanent BIV in 2 groups of patients : pts with a previously implanted PM sub- 
sequantly upgraded to BIV (PM+ ; n = 23) and pts without (PM- ; n = 92). Comparisons 
were performed between baseline and end FU under BIV in each group. 
Conclusion : Permanent BIV provided similar symptomatic relief in both AHF patients with 
or without previously implanted PM. While the age and AF prevalence were significantly 
higher in PM+ Lots, the mortality rate was identical in both groups. The magnitude of QRS 
reduction with BIV was significantly greater in PM+ pts. 
PM+ PM+ PM+ PM- PM- PM- 
Baseline P BIV Baseline P BIV 
Age (Years) 71 ± 7 66 ± 9 
AF/SS R 11/12 27/65 
FU time (m) 18 ± 11 19 ± 13 
NYHA class 3.3 ± 0.5 < 0.01 2.4 ± 1 3.3 ± 0.5 < 0.01 2.2 ± 0.7 
QRS (ms) 204 ± 30 < 0.01 157 ± t9 181 ± 23 < 0.01 158 ± 19 
Peak VO2 (ml/kg/min) 12±4 <0.01 16±3 13±5 <0.01 16±4 
LVEF (%) 20±8 <0.05 27±7 22¢8 <0.01 27±10 
Mortality (%) 19 21 
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815-4 Delayed Electrical Activation of the Left Septum and 
Lateral Wall In Left Bundle Branch Block: Insight From 
3-D Electroanatomlcal Mapping 
Apealo Audcchio. Christoph J. Geller, Sven Reek, Andreas Goetts, Hslmut U. Klein, Di~ 
Cardiology - University Hospital. Magdeburg, Germany. 
Background. The sequence of right and left ventdcular activation in patients with heart 
failure and left bundle branch block (LBBB) has not been characterized in detail. 
Methods. Using a 3-D electreanatomical nonfluoroscopic mapping system, the right (RV) 
and left (LV) ventdcular activation sequence was studied in 70 patients (48 males, mean 
age 61 +/- 7 yrs) with LBBB, dilated cardiomyopathy of any etiology, and heart failure 
(NYHA class >ti). The total RV and LV activation time, the time to LV breakthrough (LV- 
B), and the time to LV free wall activation (LV-FW) was analyzed. The area delimited by 
the isochrenal line corresponding to the last 1/3 of LV total activation was calculated 
(Area of Delayed Activation). This area was normalized (%) to the total LV surface celcu- 
;ated by the mapping system. 
Results. The LV-B was largely different in the study cohort: 14 patients (20%) have had a 
normal (<20 msec) LV-B (Group I), whereas a markedly prolonged LV-B (range 30-70 
msec) was present in 56 patients (Group II). Only the duration of the QRS complex distin- 
guished the 2 Groups: 139+/-20 msec, and 170+/-26 msec (p<0.01), in Group I and II 
respectively. The total RV activation time was similar in Group I (83 +/- 5 msec) and 
Group II (78 +/- 22, p=NS). The total LV activation time also did not differ between Group 
I (120 +/- 23 rnsec) and Group ti (110 +/- 17, p=NS). The LV activation at superior, ante- 
rior, and inferior wall was similar between the 2 Groups. In contrast, the LV-FW time was 
significantly shorter in Group I (47 +/- 11 msec) than in Group II (57 +/- 13 msec, p<0.05). 
Furthermore, the extent of the area of delayed LV activation normalized for the total LV 
surface was much larger in Group II (36 +/-2%) than in Group I (31 +/-3%), p<0.05). 
Conclusions. Despite similar RV and LV total activation time in patients with LBBB and 
heart failure, abnormal electrical activation are selectively localized at the LV septum and 
LV-FW. Patients with LBBB and QRS >150 msec frequently have had a prolonged LV 
breakthrough time and larger area of delayed ventricular activation than patients with 
LBBB, but narrow QRS duration (120-150 msec). These results might have important 
clinical implications for candidate to cardiac resynchronization therapy. 
Noon 
815-5 Echocard iograph ic  and Neurohormons l  Pred ictors  of  
Left  Ventr icu lar  Reverse Remodel ing  Af ter  Blventricular 
Pacing fo r  Heart  Fai lure 
Cheuk-Man Yu, Gary M. Nicholls, John E. Sanderson, Steve Fisher, Man-Oi Tang, Hong 
Lin, Chu-Pak Lau. University of Hong Kong, Hong Kong, t-long Kong, University of 
Otago, Christchurch, New Zealand. 
Background: Biventdcular pacing has been demonstrated recently to result in left ventric- 
ular (LV) reverse remodeling (RR) in heart failure patients with wide QRS complexes. 
This study investigated the clinical, echocardiographic and neurohormonal predictors of 
RR after biventricular pacing therapy. Methods: Nineteen patients (mean age: 82 ± 14 
yrs, 14 males) received biventdcular pacing therapy for 3 months were studied by 
echocardiogrephy with tissue Doppler imaging and same day plasma neurohormones 
were assayed. Results: There were 10 responders of RR (defined as reduction of LV 
end-systolic volume [LVVs] by >10%) and 9 non-responders (change in LVVs <10%). 
The ejection fraction was increased in the rasponders, but was unchanged in the non- 
responders (13.4 ± 9.6 Vs -3.0 ± 7.8%, p = 0.001). The responders also had more severe 
LV systolic asynchreny as shown by the standard deviation of the time to peak systolic 
contraction of the 12 LV segments (Ts-SD) (39.4 ± 9.8 Vs 23.4 ± 8.9 ms, p = 0.003). The 
plasma concentration of brain natduretic paptide (BNP) and endothelin were also lower 
in responders than non-responders. Significant predictors of RR include a wide QRS 
duration (r = -0.52, p = 0.02), a large pre-paclng LVVs (r = -0.58, p = 0.009), more severe 
systolic asynchrony (r = -0.70, p = 0.002), and low BNP (r = 0.66, p = 0.02) and endothe- 
lin levels (r = 0.69, p = 0.01 ). By stepwise multiple regression analysis, independent pre- 
dictors of RR include LVVs (beta = -0.11, p = 0.02), Ts-SD (beta = -0.83, p = 0.03), and 
BNP level (beta = 0.31, p = 0.008). When combining Ts-SD and BNP, the sensitivity and 
specificity for predicting a successful RR were 89% and 100%, respectively. Conclu- 
sions: LV RR after biventdcular pacing was found in those with more severe LV enlarge- 
ment and systolic asynchrony, but relatively low BNP levels, suggesting that pacing 
therapy should be initiated before reaching end-stage heart failure biochemically. 
